by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: There is a paucity of real-world studies examining stroke/systemic embolism (S/SE) and major bleeding (MB) risks among non-valvular atrial fibrillation (NVAF) patients who switched from warfarin to a direct oral anticoagulant. Methods: A...
by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the differential prescription patterns of OACs and outcomes in AF patients when categorized by male versus female sex. The primary objectives...
by [email protected] | Mar 7, 2023 | Cardiovascular Posters, Presentations
Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the prescription patterns of OAC prescription and outcomes in AF patients among different age groups. The primary objectives of this study...
by [email protected] | Feb 16, 2023 | Endocrine, Publication
Abstract Aims To identify patient clusters with poor glucose control among type 2 diabetes mellitus (T2DM) patients with obesity who are receiving basal-bolus insulin and to identify the potential therapeutic inertia factors associated with poor control. Methods...
by [email protected] | Feb 14, 2023 | Cancer (blood), Hematology, Oncology, Publication
ABSTRACT Background: Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitinib as the first Janus kinase 1...
